A Pilot Study of Acupuncture to Treat Chemotherapy-Related Nerve Damage

Full Title

Acupuncture for Persistent Chemotherapy-induced Peripheral Neuropathy Symptoms in Solid Tumor Survivors: A Pilot Study

Purpose

Peripheral neuropathy is tingling, numbness, and pain in the hands and feet and is a side effect of some chemotherapy drugs. There is no cure, though pain medicines can help relieve symptoms in some people. In this study, researchers are assessing the effectiveness of acupuncture to treat nerve damage in people who received chemotherapy for solid tumors.

Acupuncture involves the placement of very thin, sterile needles at certain energy points in the body, and is thought to work by unblocking the body’s energy pathways. In this study, patients will receive either real acupuncture (placement of needles at key energy points that may help relieve specific symptoms), placebo acupuncture (placement of needles on various other parts of the body), or standard medical care.

Eligibility

This study is for people age 18 and older who have moderate to severe neuropathy following chemotherapy for a solid tumor. Chemotherapy must have ended at least 3 months before entering the study.

For more information about this study, please contact our study staff at 646-888-0811 or email us at medacuCIPN@mskcc.org.

Protocol

17-298

Phase

Pilot

Investigator

Co-Investigators